Gold Tops $4,000 & Pearl Street Dental Scales to 54 Practices
Gold surges past $4,000, the Fed's path stays murky, and Pearl Street Dental Partners hits 54 locations in this week's deals and markets roundup.
Healthcare Practice & Business Deals

This week’s most notable small-to-medium healthcare business activity centers on the dental group space, where two DSOs offered a candid look at their acquisition strategies and scaling milestones.
Pearl Street Dental Partners reaches 54 practices. Co-founders David Meece (CEO) and Dr. Robby Jennings (Chief Clinical Officer) detailed how Pearl Street Dental Partners has grown to 54 practices by prioritizing doctor autonomy, clinical education, mentorship, and culture. The DSO spotlighted its approach to building clinical confidence across its network — a model that positions it as a mid-market group competing on culture rather than pure scale.
42 North Dental on acquisition realities in 2026. Priyanki Amroliwala and Greg Wappett, Chief Development Officer of 42 North Dental, outlined the group’s current acquisition strategies and doctor-recruitment priorities in a newly released podcast episode. Wappett addressed the realities of getting deals done in the current environment, including tighter valuations and heightened competition for quality practices — themes resonating across the DSO sector this year.
Integrated Dental Partners makes the case for regional DSOs. Arun Ramakumar, Founder and CEO of Integrated Dental Partners, argued publicly that regional DSO models may be better positioned than national groups to preserve what makes neighborhood dental practices work. His commentary reflects a growing debate within dentistry over whether scale or proximity better protects practice culture and patient relationships — a consideration directly relevant to sellers evaluating DSO offers.
Note: No specific acquisition dollar figures or transaction closings were disclosed in this week’s available healthcare deal sources. The activity above reflects the most concrete named-party business developments reported.
Global Markets & Macro

Markets closed a turbulent week with cautious optimism, but several powerful cross-currents — a new Fed chair, rising gold, falling oil, and a deepening AI stock rout — are keeping investors on edge.
Gold surges above $4,000 as inflation data tempers rate-hike fears. Gold extended gains above $4,000 an ounce on Friday after the latest US inflation print tempered expectations for an interest-rate hike. The move capped a volatile week that had earlier seen bullion drop to its lowest level since November. The print reinforced ongoing uncertainty about the trajectory of monetary policy under new Fed Chair Kevin Warsh.
Federal Reserve direction remains a black box under Chair Warsh. New Fed Chair Kevin Warsh is offering markets little forward guidance, leaving open a wide range of outcomes — from multiple rate hikes beginning as soon as late July to an indefinite hold. Warsh stated plainly at his first press conference: “I can’t give any forward guidance about what we’re going to do next.” The Fed’s preferred inflation measure has risen 3.4% over the past 12 months, and inflation has now exceeded the Fed’s target for five consecutive years. Analysts are watching closely for any signal on whether Warsh views recent price pressures as transitory or as requiring a policy tightening response.
Oil falls below $70 as Hormuz transits resume. US crude oil fell below $70 a barrel as tanker traffic through the Strait of Hormuz accelerated, easing the supply-disruption premium that had pushed energy prices higher. Tanker earnings dropped sharply — by as much as $200,000 — as more ships re-entered the waterway, even as a Thursday attack on a cargo ship briefly renewed concerns about passage safety. The Strait’s reopening is also expected to help reduce one of the key one-off inflation drivers cited by Fed watchers.
AI stock volatility hammers tech and emerging markets. Wall Street ended the week with mild gains overall, but high-profile technology names experienced intense volatility, testing investors after a sharp run-up from war-fueled lows. The AI-driven selloff hit emerging-market equities hardest, with EM stocks posting their worst weekly decline since early March — South Korean equities were among the most affected. Bloomberg noted a subtle but meaningful shift in the AI investment zeitgeist, with investor enthusiasm beginning to rebalance after months of euphoria.
Boeing lands $3.62B order from China Southern Airlines. Boeing secured a jet order from China Southern Airlines valued at $3.62 billion — a significant win for the US manufacturer, which has seen orders from Asia’s largest aviation market dry up over the past decade. The deal arrives as trade tensions and USMCA renegotiation uncertainty continue to weigh on global industrial supply chains, and as Volkswagen separately announced plans to cut up to 100,000 jobs in one of the largest corporate restructurings in recent memory.
What to Watch
The week ahead brings a critical intersection of policy and markets: Fed Chair Warsh’s next public appearances will be parsed intensely for any hint of a rate path, while oil prices and Hormuz shipping data will determine whether the inflation relief seen this week holds. In the dental and broader healthcare M&A market, DSO deal activity is being shaped by tighter valuations and a sharper seller focus on cultural fit — making the regional-versus-national DSO debate one that practice owners weighing an exit should follow closely. Meanwhile, the AI stock rotation and ongoing US-China technology competition signal that technology sector volatility is far from over, with potential ripple effects for the private equity and growth capital that funds much of healthcare services consolidation.
